Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:title>SUMMARY</jats:title><jats:p>Mucosal-associated invariant T (MAIT) cells are a subset of innate T lymphocytes activated by bacteria that produce vitamin B2 metabolites. Mouse models of infection have demonstrated a role for MAIT cells in antimicrobial defence. However, proposed protective roles of MAIT cells in human infections remain unproven and clinical conditions associated with a selective absence of MAIT cells have not been identified. We report that typhoidal and non-typhoidal <jats:italic>S. enterica</jats:italic> strains generally activate MAIT cells. However, African invasive disease-associated multidrug-resistant <jats:italic>S.</jats:italic> Typhimurium sequence type 313 lineage 2 strains escape MAIT cell recognition through overexpression of <jats:italic>ribB</jats:italic>, a bacterial gene that encodes the 4-dihydroxy-2-butanone 4-phosphate synthase enzyme of the riboflavin biosynthetic pathway. This MAIT cell-specific phenotype did not extend to other innate lymphocytes. We propose that <jats:italic>ribB</jats:italic> overexpression is an evolved trait that facilitates evasion from immune recognition by MAIT cells and contributes to the invasive pathogenesis of <jats:italic>S.</jats:italic> Typhimurium sequence type 313 lineage 2 <jats:italic>in vivo</jats:italic>.</jats:p>

Original publication




Journal article


Cold Spring Harbor Laboratory

Publication Date